Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The CFTR gene variants in paediatric nasal polyposis: a study in the Italian population.

Rhinology·2025
Same author

Search for Fractionally Charged Particles in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2025
Same author

Observation of the <math> </math> decay.

The European physical journal. C, Particles and fields·2024
Same author

Search for Leptonic Decays of Dark Photons at NA62.

Physical review letters·2024
Same author

Observation of the ϒ(3S) Meson and Suppression of ϒ States in Pb-Pb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2024
Same author

Search for Narrow Trijet Resonances in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2024

Related Experiment Video

Updated: May 29, 2026

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

Remote telematic control in cystic fibrosis.

F Murgia1, M Cilli, E Renzetti

  • 1Cystic Fibrosis Unit, Pediatric Medicine Department, Epidemiology Unit, Bambino Gesù Pediatric Hospital, IRCCS, Rome, Italy. telemedicina@opbg.net

La Clinica Terapeutica
|September 14, 2011
PubMed
Summary

Remote telematic tracking of cystic fibrosis (CF) outpatients using telehomecare shows promise for improved care and reduced costs. Careful study and attention to new issues are essential for successful telemedicine implementation.

More Related Videos

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice
08:55

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice

Published on: July 4, 2018

Related Experiment Videos

Last Updated: May 29, 2026

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
08:00

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice
08:55

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice

Published on: July 4, 2018

Area of Science:

  • Medical Informatics
  • Respiratory Medicine
  • Telehealth

Background:

  • Describes the daily practice of remote telematic tracking for cystic fibrosis (CF) outpatients.
  • Highlights improvements achieved through telehomecare experience.

Purpose of the Study:

  • To detail the intervention parameters and data management in a telehomecare project for CF patients.
  • To outline patient training, communication protocols, and satisfaction surveys.

Main Methods:

  • Involves approximately 30 CF patients in a telehomecare project.
  • Utilizes spreadsheet format for performance tracking and intervention parameters.
  • Includes patient training, communication with patients and Vivisol, and satisfaction surveys.

Main Results:

  • Data collected from February 2010 to May 2011.
  • Recorded 882 total transmissions, 1317 spirometry tests, and 291 SaO2 measurements.
  • Achieved 8.91% compliance and 722 total contacts, including 494 phone calls.

Conclusions:

  • Telehomecare shows potential for improving patient assistance, working conditions, and reducing costs.
  • Discusses patient compliance, efficacy of mobile phone contact, and symptom detection for pulmonary relapse.
  • Addresses medico-legal aspects, data privacy, team needs, and clinical risk management in telemedicine.